Yvette Bernal

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

17h-index7.9kcitations38works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(35), Acute Lymphoblastic Leukemia research(9), Chronic Lymphocytic Leukemia Research(7), Biosimilars and Bioanalytical Methods(7), Lymphoma Diagnosis and Treatment(4)

Publications38 total

Infusional N-Acetylcysteine Enhances CAR T Cell Persistence in Patients with Aggressive B-Cell Lymphomas
Transplantation and Cellular Therapy·2025· 1 cited
Data from Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia
2023Open Access
Figure S1, Figure S2, Figure S3, Figure S4 from Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia
2023Open Access
Table S1, Table S2, Table S3, Table S4 from Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia
2023Open Access
Data from Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia
2023Open Access
Figure S1, Figure S2, Figure S3, Figure S4 from Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia
2023Open Access
Table S1, Table S2, Table S3, Table S4 from Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia
2023Open Access
Outcomes of relapsed B-cell acute lymphoblastic leukemia after sequential treatment with blinatumomab and inotuzumab
Blood Advances·2022· 26 citedOpen Access
Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult acute lymphoblastic leukemia
Leukemia·2021· 37 citedOpen Access
Clinical Factors Associated with Improved Survival Following Allogeneic HSCT after CD19 CAR Therapy in Adult Patients with Relapsed B-ALL
Blood·2019
CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma
Blood·2019· 90 citedOpen Access
PHASE I CLINICAL TRIAL OF CD19‐TARGETED 19‐28Z/4‐1BBL “ARMORED” CAR T CELLS IN PATIENTS WITH RELAPSED OR REFRACTORY NHL AND CLL INCLUDING RICHTER TRANSFORMATION
Hematological Oncology·2019· 16 cited
S1634 A PHASE I FIRST‐IN‐HUMAN CLINICAL TRIAL OF CD19‐TARGETED 19–28Z/4–1BBL “ARMORED” CAR T CELLS IN PATIENTS WITH RELAPSED OR REFRACTORY NHL AND CLL INCLUDING RICHTER TRANSFORMATION
HemaSphere·2019· 3 citedOpen Access
Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult ALL.
Journal of Clinical Oncology·2019· 13 cited
Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLL
JCI Insight·2019· 98 citedOpen Access
A Phase I First-in-Human Clinical Trial of CD19-Targeted 19-28z/4-1BBL "Armored" CAR T Cells in Patients with Relapsed or Refractory NHL and CLL Including Richter's Transformation
Blood·2018· 44 cited
Clinical Responses and Pharmacokinetics of MCARH171, a Human-Derived Bcma Targeted CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma: Final Results of a Phase I Clinical Trial
Blood·2018· 99 cited
Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia
Cancer Discovery·2018· 887 citedOpen Access
Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia
Blood Advances·2018· 158 citedOpen Access
Development and Evaluation of a Human Single Chain Variable Fragment (scFv) Derived Bcma Targeted CAR T Cell Vector Leads to a High Objective Response Rate in Patients with Advanced MM
Blood·2017· 17 cited
page 1 of 2Next →

Frequent Co-authors

Renier J. Brentjens(33), Isabelle Rivière(32), Michel Sadelain(31), Jae H. Park(27), Elizabeth Halton(25), Xiuyan Wang(23), Terence J. Purdon(18), Brigitte Sénéchal(17), Kevin J. Curran(15), Mithat Gönen(11), Jessica Flynn(10), Claudia Diamonte(10), Craig S. Sauter(10), Bianca Santomasso(9), Elena Mead(9), Yongzeng Wang(7), Sergio Giralt(7), Darin Salloum(7), Justin R. Cross(7), Hui Liu(7)